Please log in to view this page
Username
Password
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
